The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2020

Filed:

Nov. 23, 2016
Applicant:

Daewoong Co., Ltd., Gyeonggi-do, KR;

Inventors:

Kyoung-Yun Kim, Jeollabuk-do, KR;

Chung Sei Kim, Seoul, KR;

Myung Seob Kim, Gyeonggi-do, KR;

Hye-Young Sul, Gyeonggi-do, KR;

Assignee:

DAEWOONG CO., LTD., Gyeonggi-Do, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/52 (2006.01); B01D 15/36 (2006.01); B01D 61/14 (2006.01); B01D 61/58 (2006.01); C07K 14/33 (2006.01);
U.S. Cl.
CPC ...
C12N 9/52 (2013.01); B01D 15/362 (2013.01); B01D 15/363 (2013.01); B01D 61/145 (2013.01); B01D 61/147 (2013.01); B01D 61/58 (2013.01); C07K 14/33 (2013.01); C12Y 304/24069 (2013.01); B01D 2315/16 (2013.01);
Abstract

The present invention relates to a method for producing a botulinum toxin comprising: (a) treating a culture of a botulinum toxin-producing strain with acid to form a botulinum toxin-containing precipitate; (b) adding a buffer to the botulinum toxin-containing precipitate of step (a), followed by clarification by at least one method selected from the group consisting of depth filtration (DF), microfiltration (MF), ultrafiltration (UF), sterile filtration, membrane chromatography (MC) and centrifugation; (c) subjecting the botulinum toxin-containing solution of step (b) to UF diafiltration, ammonium sulfate precipitation or hydrochloric acid precipitation, and then diluting a retentate resulting from the UF diafiltration in a buffer or dissolving a precipitate resulting from the ammonium sulfate precipitation or hydrochloric acid precipitate in a buffer; and (d) subjecting the retentate dilution, ammonium sulfate precipitate solution or hydrochloric acid precipitate solution of step (c) to anion-exchange chromatography (AEX) to purify the botulinum toxin.


Find Patent Forward Citations

Loading…